Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

What FDA's abortion pill changes mean

Walgreens and CVS can now sell the abortion pill — but will they?

Salon

UK signs groundbreaking mRNA cancer vaccine research agreement

The partnership with German pharmaceutical company BioNTech will be one of the first of its kind

Evening Standard

Structural engineers Cundall report strong year with international expansion under way

The firm has delivered projects tied to the 2022 World Cup and a record-breaking rollercoaster in the Middle East

Birmingham Post

From analysis to the latest developments in health,
read the most diverse news in one place.

Uzbekistan arrests four over Indian cough syrup deaths

Uzbekistan has arrested four people in an investigation into the deaths of 19 children who consumed cough syrup made by Indian drug maker Marion Biotech, the Uzbek state security service said on Friday.

Reuters

2023 could be a banner year for prescription drugs

There's a large pipeline of promising yet expensive drugs that could get approved.

Axios

Pneumagen appoints new chair

New hire brings more than 30 years worth of biotech industry experience

Insider UK

NI pharmacies facing shortage of cough and cold medicines amid high levels of winter illness

Pharmacies are struggling to get hold of cough and cold medicines

Belfast Live

Read news from The Economist, FT, and more,
with one subscription

BioNTech signs deal with UK for personalised cancer therapies

BioNTech SE has signed a deal with the UK government to enrol up to 10,000 patients in clinical trials by the end of 2030 for personalised cancer therapies, the German drug maker said.

Reuters

38 jobs lost as ODx Innovations collapses

Inverness-based medical technology firm ran out of funds and appointed administrators just before Christmas

Insider UK

3 High-Quality Stocks That Can Help Take Your Portfolio to the Next Level

With encouraging economic data discouraging investors, the market is unlikely to stabilize anytime soon. Therefore, loading up on fundamentally strong stocks AbbVie (ABBV), Gartner (IT), and Dropbox (DBX) could keep portfolios buoyant and generate alpha in an otherwise chronic bear market. Continue reading….

StockNews.com

Walgreens, CVS to seek certification for dispensing abortion pills

Once certified, the two largest national pharmacy chains will be able to prescribe mifepristone, a pill used in medication abortions.

Chicago Sun-Times

Time running out for national apology as survivors of catastrophic drug thalidomide left feeling 'forgotten'

Amid rapidly declining health, thalidomide survivors are still waiting for a national apology after a drug that caused catastrophic birth deformities in unborn babies continued to be sold in pharmacies.

ABC News

Government claims more than £130 million after suing pandemic gown supplier

Lawyers representing Health and Social Care Secretary Steve Barclay have outlined detail of a High Court claim against PPE Medpro.

The Independent UK

Children's Calpol 'non-existent' on some shop shelves as flu and Covid surges

A warning has been issued by health chiefs with regards to low supplies of common cold and flu medicines, while pharmacists struggle to stock up on Calpol, certain painkillers and throat lozenges

Chronicle Live

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Want Passive Income in a Bear Market? Check out This Biotech Stock

With the minutes of the latest Fed meeting showing that interest rates will keep increasing this year, the economy is widely expected to enter a recession. Amid the expected downturn this year, it could be wise to buy biotech stock Gilead Sciences (GILD) due to its solid growth prospects and…

Chronicle Live

Tributes to North East Professor Sir Michael Rawlins who fought to protect patients from medicine side-effects

Professor Sir Michael Rawlins led a long and distinguished career at the forefront of patient safety

The Guardian - UK

PPE Medpro: UK government alleges firm supplied defective gowns to NHS

Exclusive: DHSC alleges gowns were not sterile, could not be used within NHS ‘for any purpose’, and technical labelling was ‘invalid’

Axios

Why we (still) can't find any children's Tylenol

For months, children’s versions of Tylenol and Motrin have felt about as hard to find as a Taylor Swift concert ticket.

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

Ballarat's new Priority Primary Care Centre is yet to relieve pressure on ED, health chief says

The town's Priority Primary Care Centre is "making a real difference to emergency department demand" by seeing up to 68 patients a day, the state government says. But the local health service's chief executive disagrees.

Tribune News Service

Walgreens confirms plans to sell abortion pills under new FDA rules

Walgreens expects to offer abortion pills after the Food and Drug Administration changed its rules for the drug.

The Guardian - UK

Shortage of cold medicines in UK is government’s fault, say pharmacists

Pharmacy leaders cite ministers’ ‘lack of planning’ amid problems obtaining common products

Daily Mirror

Calpol 'non-existent' as basic medicines run low and flu, Covid and Strep A surge

Health chiefs have issued a warning about low supplies of common cold and flu medicines as pharmacists struggle to get hold of Calpol, throat lozenges and some painkillers

Manchester Evening News

'We will have something that will do the job': Message from Greater Manchester pharmacy leader amid cold and flu medicines shortage

"People have been only buying it when they need it and that's helping ease the situation."

Manchester Evening News

Supermarkets respond to cold and flu drugs shortage warning

Members of the public have been told by leading pharmacists to not panic and that support for patients will be made available

The Independent UK

Oklahoma AG announces 4 new opioid settlements worth $226M

Oklahoma has entered into four new settlements with opioid makers and distributors totaling more than $226 million

1 … 65 66 67 68

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.